These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative analysis of peripheral stem cells collected and transplanted in combination with granulocyte-macrophage and granulocyte colony-stimulating factors. Handgretinger R; Klingebiel T; Herter M; Lang P; Gisselhart A; Dopfer R; Scheel-Walter H; Ehrlich H; Niethammer D Prog Clin Biol Res; 1994; 389():479-86. PubMed ID: 7535457 [No Abstract] [Full Text] [Related]
3. Kinetics of low and high dose granulocyte/macrophage colony stimulating factor mobilization of peripheral blood stem cells. Jackson JD; Letheby B; O'Kane Murphy B; Costas P; Wang PN; Bishop MR; Kessinger A; Warkentin PI Prog Clin Biol Res; 1994; 389():471-7. PubMed ID: 7535456 [No Abstract] [Full Text] [Related]
4. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867 [TBL] [Abstract][Full Text] [Related]
5. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood. Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347 [TBL] [Abstract][Full Text] [Related]
6. Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapy. Lee WJ; Zimmerman T; Meyers S; Bender JG; Williams SF Prog Clin Biol Res; 1994; 389():421-7. PubMed ID: 7535451 [No Abstract] [Full Text] [Related]
7. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF). Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113 [TBL] [Abstract][Full Text] [Related]
8. CD34 analysis in erythropoietin mobilized peripheral blood stem cells. O'Kane-Murphy B; Jackson JD; Kuszynski C; Costas P; Wang PN; Warkentin PI; Kessinger A Prog Clin Biol Res; 1994; 389():371-6. PubMed ID: 7535444 [No Abstract] [Full Text] [Related]
9. Expansion of cord blood progenitors and use for hemopoietic reconstitution. Gabutti V; Timeus F; Ramenghi U; Crescenzio N; Marranca D; Miniero R; Cornaglia G; Bagnara GP Stem Cells; 1993 Jul; 11 Suppl 2():105-12. PubMed ID: 7691315 [TBL] [Abstract][Full Text] [Related]
12. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow. Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502 [TBL] [Abstract][Full Text] [Related]
13. Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors. Ferlazzo G; Spaggiari GM; Semino C; Melioli G; Moretta L Eur J Immunol; 2000 Mar; 30(3):827-33. PubMed ID: 10741398 [TBL] [Abstract][Full Text] [Related]
14. Impact of the degree of maturation and differentiation of CD34+ cells in grafts of different origin on the duration of aplasia. Wunder E; Sovalat H; Liang H; Becker M; Henon P Prog Clin Biol Res; 1994; 389():345-50. PubMed ID: 7535441 [No Abstract] [Full Text] [Related]
15. Characterization of peripheral blood progenitor cells mobilized by nartograstim (N-terminal replaced granulocyte colony-stimulating factor) in normal volunteers. Maruyama K; Tsuji K; Tanaka R; Yamada K; Kodera Y; Nakahata T Bone Marrow Transplant; 1998 Aug; 22(4):313-20. PubMed ID: 9722064 [TBL] [Abstract][Full Text] [Related]
16. Enrichment of G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation by negative selection. Dreger P; Steinmann J; Drost R; Eckstein V; Suttorp M; Müller-Ruchholtz W; Löffler H; Schmitz N Prog Clin Biol Res; 1994; 389():407-13. PubMed ID: 7535449 [No Abstract] [Full Text] [Related]
17. Characterization of CD34+ cells mobilized to the peripheral blood during the recovery from cyclophosphamide chemotherapy. Bender JG; Unverzagt KL; Walker DE; Lee W; Lum L; Van Epps DE; Williams SF; To LB Prog Clin Biol Res; 1992; 377():575-82. PubMed ID: 1279727 [No Abstract] [Full Text] [Related]
18. Quality control for peripheral stem cell collection: the Ottawa experience. Giulivi A; Huebsch LB; Van der Jagt R; Markman S; Fuller V; Birch P; Demone J; McDiermid S; Rutherford B Prog Clin Biol Res; 1994; 389():753-9. PubMed ID: 7535465 [No Abstract] [Full Text] [Related]
19. Expansion of human umbilical cord blood CD34+ hematopoietic progenitor cells with recombinant growth factors. Akabutu JJ; Chan JR Prog Clin Biol Res; 1994; 389():399-404. PubMed ID: 7535448 [No Abstract] [Full Text] [Related]
20. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens. Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]